Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Medtronic
Colorcon
Moodys
Merck

Last Updated: May 20, 2022

Details for New Drug Application (NDA): 020762


✉ Email this page to a colleague

« Back to Dashboard

NDA 020762 describes NASONEX, which is a drug marketed by Organon and Perrigo Pharma Intl and is included in two NDAs. Additional details are available on the NASONEX profile page.

The generic ingredient in NASONEX is mometasone furoate. There are thirty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 020762
Tradename:NASONEX
Applicant:Organon
Ingredient:mometasone furoate
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020762

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY, METERED;NASALStrength0.05MG/SPRAY
Approval Date:Oct 1, 1997TE:RLD:Yes

Expired US Patents for NDA 020762

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon NASONEX mometasone furoate SPRAY, METERED;NASAL 020762-001 Oct 1, 1997 See Plans and Pricing See Plans and Pricing
Organon NASONEX mometasone furoate SPRAY, METERED;NASAL 020762-001 Oct 1, 1997 See Plans and Pricing See Plans and Pricing
Organon NASONEX mometasone furoate SPRAY, METERED;NASAL 020762-001 Oct 1, 1997 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Baxter
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.